Status:
COMPLETED
A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
Lead Sponsor:
Narrows Institute for Biomedical Research
Collaborating Sponsors:
L'Oreal
Conditions:
Post Inflammatory Hyperpigmentation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a single-center, prospective, non-blinded, non-randomized 12 week clinical study to evaluate the efficacy of a SkinCeuticals comprehensive skin care regimen in the reduction of post inflammato...
Eligibility Criteria
Inclusion
- Men and women ages 18+.
- Clinical diagnosis of Post Inflammatory Hyperpigmentation
- Non-Caucasian
- Fitzpatrick skin types IV-VI
- Available and willing to comply with study instructions and attend all study visits.
- Able and willing to provide written and verbal informed consent.
Exclusion
- Subject has any skin pathology or condition that could interfere with the evaluation of the test products or requires the use of interfering topical or systemic therapy.
- Caucasian/ Non-Hispanic
- Subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.
- Pregnant, lactating, or is planning to become pregnant during the study.
- Subject is currently enrolled in an investigational drug or device study.
- Subject has received an investigational drug or has been treated with an investigational device within 30 days prior to the initiation of treatment (baseline).
- Study participant has facial hair that could interfere with the study assessments in the opinion of the investigator.
- Study participant is unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function.
- Subject has known hypersensitivity or previous allergic reaction to any of the active or inactive components of the test articles.
- Subject has the need or plans to be exposed to artificial tanning devices or excessive sunlight during the trial.
Key Trial Info
Start Date :
February 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06938815
Start Date
February 28 2025
End Date
July 20 2025
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Harbor VA Brooklyn Campus
Brooklyn, New York, United States, 11209